Vaccines, blood, antisera, toxins and cultures in   Uganda

Exports In 2022, Uganda exported $45M in Vaccines, blood, antisera, toxins and cultures, making it the 51st largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 8th most exported product in Uganda. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Uganda are: United States ($44.8M), Belgium ($112k), India ($32.4k), Ethiopia ($7.21k), and Netherlands ($5.6k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Uganda between 2021 and 2022 were United States ($44.8M), Belgium ($68.6k), and India ($20.4k).

Imports In 2022, Uganda imported $235M in Vaccines, blood, antisera, toxins and cultures, becoming the 75th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 1st most imported product in Uganda. Uganda imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($107M), United States ($60.1M), India ($25M), France ($9.86M), and South Korea ($5.75M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Uganda between 2021 and 2022 were Belgium ($23.3M), France ($9.25M), and United States ($5.95M).